Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer

Supot Pongprasobchai, Rahul Pannala, Thomas Christopher Smyrk, William Bamlet, Suresh Pitchumoni, Andrei Ougolkov, Mariza De Andrade, Gloria M Petersen, Suresh T Chari

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objectives: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (≤2 cm) pancreatic cancer (PaC) as compared to large PaC. Methods: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. Results: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7%, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95% confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95% CI 2.4-10.1). Conclusion: Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage.

Original languageEnglish (US)
Pages (from-to)587-592
Number of pages6
JournalPancreatology
Volume8
Issue number6
DOIs
StatePublished - Oct 2008

Fingerprint

Pancreatic Neoplasms
Survival
Neoplasms
Kaplan-Meier Estimate
Survival Analysis
Proportional Hazards Models
Multivariate Analysis
Odds Ratio
Databases
Confidence Intervals
Pathology
Neoplasm Metastasis

Keywords

  • Small pancreatic cancer
  • Survival prediction
  • Tumor differentiation
  • Tumor stage

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Hepatology

Cite this

Pongprasobchai, S., Pannala, R., Smyrk, T. C., Bamlet, W., Pitchumoni, S., Ougolkov, A., ... Chari, S. T. (2008). Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer. Pancreatology, 8(6), 587-592. https://doi.org/10.1159/000161009

Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer. / Pongprasobchai, Supot; Pannala, Rahul; Smyrk, Thomas Christopher; Bamlet, William; Pitchumoni, Suresh; Ougolkov, Andrei; De Andrade, Mariza; Petersen, Gloria M; Chari, Suresh T.

In: Pancreatology, Vol. 8, No. 6, 10.2008, p. 587-592.

Research output: Contribution to journalArticle

Pongprasobchai, S, Pannala, R, Smyrk, TC, Bamlet, W, Pitchumoni, S, Ougolkov, A, De Andrade, M, Petersen, GM & Chari, ST 2008, 'Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer', Pancreatology, vol. 8, no. 6, pp. 587-592. https://doi.org/10.1159/000161009
Pongprasobchai S, Pannala R, Smyrk TC, Bamlet W, Pitchumoni S, Ougolkov A et al. Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer. Pancreatology. 2008 Oct;8(6):587-592. https://doi.org/10.1159/000161009
Pongprasobchai, Supot ; Pannala, Rahul ; Smyrk, Thomas Christopher ; Bamlet, William ; Pitchumoni, Suresh ; Ougolkov, Andrei ; De Andrade, Mariza ; Petersen, Gloria M ; Chari, Suresh T. / Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer. In: Pancreatology. 2008 ; Vol. 8, No. 6. pp. 587-592.
@article{f38fdc42665a47fbbe4034e095091d5e,
title = "Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer",
abstract = "Objectives: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (≤2 cm) pancreatic cancer (PaC) as compared to large PaC. Methods: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. Results: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7{\%}, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95{\%} confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95{\%} CI 2.4-10.1). Conclusion: Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage.",
keywords = "Small pancreatic cancer, Survival prediction, Tumor differentiation, Tumor stage",
author = "Supot Pongprasobchai and Rahul Pannala and Smyrk, {Thomas Christopher} and William Bamlet and Suresh Pitchumoni and Andrei Ougolkov and {De Andrade}, Mariza and Petersen, {Gloria M} and Chari, {Suresh T}",
year = "2008",
month = "10",
doi = "10.1159/000161009",
language = "English (US)",
volume = "8",
pages = "587--592",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Long-term survival and prognostic indicators in small (≤2 cm) pancreatic cancer

AU - Pongprasobchai, Supot

AU - Pannala, Rahul

AU - Smyrk, Thomas Christopher

AU - Bamlet, William

AU - Pitchumoni, Suresh

AU - Ougolkov, Andrei

AU - De Andrade, Mariza

AU - Petersen, Gloria M

AU - Chari, Suresh T

PY - 2008/10

Y1 - 2008/10

N2 - Objectives: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (≤2 cm) pancreatic cancer (PaC) as compared to large PaC. Methods: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. Results: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7%, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95% confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95% CI 2.4-10.1). Conclusion: Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage.

AB - Objectives: In a matched analysis, we investigated clinical, histopathological, and survival characteristics of small (≤2 cm) pancreatic cancer (PaC) as compared to large PaC. Methods: From the Mayo pathology database, we identified 41 consecutive patients with small PaC and 94 matched controls with margin-negative PaC >2 cm. Two experienced pathologists, who were blinded to survival data, independently reviewed tumor stage and differentiation. Kaplan-Meier survival analysis and Cox proportional hazards models were applied for data analyses. Results: In patients with localized disease (stages I and II), survival was similar in small and large PaC but survival was significantly better in small PaC with regional nodal metastasis (stage III) as compared to similar stage large PaC (5-year survival 44 vs. 7%, median survival 58 vs.18 months, p < 0.001). Well-differentiated small and large PaC had similar median survival (76 vs. 74 months, p = NS). In multivariate analysis, tumor differentiation, not tumor size, was the only independent factor predicting survival in PaC (risk ratio, RR, for moderate vs. well- differentiated: 2.6, 95% confidence interval, CI, 1.5-4.5, and RR for poorly differentiated vs. well-differentiated: 5.0, 95% CI 2.4-10.1). Conclusion: Tumor differentiation may be a better predictor of survival in resectable PaC than tumor stage.

KW - Small pancreatic cancer

KW - Survival prediction

KW - Tumor differentiation

KW - Tumor stage

UR - http://www.scopus.com/inward/record.url?scp=53449089118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53449089118&partnerID=8YFLogxK

U2 - 10.1159/000161009

DO - 10.1159/000161009

M3 - Article

C2 - 18849640

AN - SCOPUS:53449089118

VL - 8

SP - 587

EP - 592

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 6

ER -